The Henry C. Wu, James J. Leonard, and Llewellyn J. Legters Awards for Excellence in Research will be awarded annually to the USU Faculty members,in the estimation of their peers, have made the most significant contribution to the published literature during the previous three years (2018).
1. The Wu Award recognizes excellence in basic biomedical research.
2. The Leonard Award recognizes excellence in clinical research.
3. The Legters Award recognizes excellence in population health science research.
Award recipients will present an Award Lecture named in honor of Drs. Wu, Leonard, and Legters during a Research Symposium. Each awardee will also receive a memento and a cash award of $2,500.
The nominee must have a current university faculty appointment at the level of Instructor or above, excluding adjunct appointments. Any Uniformed Services University (USU) faculty member, staff, or student, may submit nominations for the Awards. Self-nominations by USU faculty are permitted. Resubmission of previous nomination packages is encouraged provided that the three-year deadline has not expired. Previous holders of the award are not eligible within the first three full years of their last award.
The nomination package should include 3 items:
1) A copy of one (1) selected original research paper(Published after January 2018) upon which the nomination is based and meets the following criteria:
(a) Paper must have been published within the last three years
(b) Paper must have been published while the nominee performed as the faculty at USU with a minimum rank of Instructor or above and must be considered a member of the Faculty Assembly
(c) The nominee must be first or senior author on the paper, in addition to having the USU affiliation documented on the published paper
(d) The research reported is original and empirical.
2) A brief statement from the nominator outlining the significance of the published original research paper.
3) A copy of the nominee’s current curriculum vitae.
The closing date for nominations is Sunday, August 1st, 2359hrs. The recipients of the Awards will be announced no later than September 10, 2021. Please send the completed nomination packages to firstname.lastname@example.org.
Details are in this announcement:
Applications instructions are spelled out in the document and are due 5 MAR 2021. Anyone applying needs to have Detailer clearance to do so.
2020 ANNUAL MEETING CALL FOR ABSTRACTS NOW OPEN
Theme – Federal Health: A Global Vision Beginning in Your Community
The portal to submit an abstract for a lecture or for a poster presentation is now open at https://www.amsus.org/events/call-for-abstracts-2/ .
- Lecture abstract deadline extended to 17 July 2020
- Poster abstract deadline extended to 3 August 2020
Please read the instructions and this year’s breakout and poster presentation topics to ensure the greatest relevance and learning objectives.
For additional details, and information, check out: www.amsus.org
This is an interesting idea from a brilliant friend that I’m passing along for the consideration of researchers out there. Take it or leave it:
I’m circulating this email in the hopes of networking my way through you to someone conducting a COVID-19 vaccine trial, or able to influence one. So far, advancing such a novel idea via emails to anyone I can think of, mid-pandemic, is not working. I’m sure the inboxes of the vaccine developers and immunologists competing to save the world are full. Among a couple dozen others, Bill Gates, Sanjay Gupta, and Dr. Fauci have yet to get back to me. If my proposal makes any sense to you, please pass it on to anyone you know who might be able to put it in front of someone who could make it happen.
I have been researching the intersection of my psychology PhD and my concerns, as a physician, regarding the challenges of implementing a Covid-19 vaccine. There is sound, supportive, but limited research suggesting that a distinctive taste stimulus paired with vaccine doses can later, and by itself, become immuno-enhancing via Pavlovian conditioning. The taste alone can then supplement or replace vaccine boosters, multiplying the availability and dramatically reducing the cost of successfully vaccinating billions worldwide against COVID-19. It would be easy and almost without additional cost to safely integrate the definitive experiment proving this concept into phase II or III trials of any prospective COVID-19 vaccine (one suggested protocol below). A major limitation is the lack of incentives for vaccine developers to pursue a paradigm that could cut their vaccine sales in half. Supporting data is in the attached brief proposal and included more extensively in a recently accepted paper of mine, also attached. I, of course, have no financial interest in the outcome of this; just trying to be helpful to the effort.
Be safe, be well.
All the best.
Kenneth Frumkin, PhD, MD, FACEP
Kenneth dot Frumkin at gmail dot com
Retired civil servant on a pension
DHA is advertising for the Director, Military Infectious Diseases Research Program. This is a great chance for an O-6/senior O-5 to shape infectious disease research and development across the enterprise. The desired report date is June 2020; eligible candidates must be in their PCS window.
Page 21 of this document contains the position qualifications. Packages need to include:
- ODC (ensure assignment history is accurate, or provide accurate assignment history as a separate document)
- Letter of Intent
- PERS/Specialty Leader concurrence/impact statement
In order to get this to DHA by their deadline, CDR Melissa Austin (contact in the global) is going to need all applications by Dec 2, 2019. Applications should be submitted to her as a single PDF.
DHA is advertising for the Director, Combat Casualty Care Research Program position. This is a great chance for an O-6/senior O-5 to shape research and development activities for lifesaving strategies/capabilities; surgical capabilities; biological, mechanical and autonomous processes; and the far forward use of artificial intelligence and telemedicine technologies for the entire Defense Health Program – definitely a way to ensure Navy Medicine needs have an advocate in the R&D world.
Desired report date is June 2020; eligible candidates must be in their PCS window.
Page 16 of this document contains the position qualifications. Packages need to include:
- ODC (ensure assignment history is accurate, or include a complete assignment history as a separate document)
- Letter of Intent
- PERS/Specialty Leader concurrence/impact statement
In order to get this to DHA by their deadline, all applications need to be sent to CDR Melissa Austin (contact is in the global) NLT Dec 2, 2019. Applications should be
submitted to her as a single PDF.
The Navy and Marine Corps Public Health Center is pleased to announce that the Navy and Marine Corps Public Health Conference is preparing for 2020, pending approval.
The conference will be held in Tidewater (Virginia) March 17-19, 2020, with the specific venue to be determined.
The deadline for poster abstract submissions is 31 October 2019 by 2359 EST. No late submissions will be accepted. Selected posters will be announced December 2019.
Please submit an abstract with a title, author names and affiliations, and a body of no more than 250 words in a Word Document to Stephen.p.rossi.civ < at > mail.mil with the email subject: Poster Abstract – Last Name, First Name.
Poster subjects should be related to public health in the military. Topics may include:
- Changes in HPW
- Diabetes Education
- MHPPH Update
- Smoking Cessation
- HPW best practices
- Program Evaluation
- Women’s Health
- Process Improvement
- Analytic techniques
- Injury Prevention
- Fleet HPW Programs
- Suicide Prevention
- Navy Needs Assessment
- Semper Fit Update
- Cancer Epidemiology
- Hospital Acquired Infections
- Behavioral Health Surveillance
- Communicable Disease Surveillance
- Public Health Dashboards and Assessment Tools
- Injury surveillance
Our conference team is working hard to develop a solid readiness-focusedagenda that addresses force health protection strategies and solutions for current and future public health threats to Navy and Marine Corps mission readiness.
We look forward to your submissions.
Earlier this month, the Senate confirmed my nomination as the Assistant Secretary of Defense for Health Affairs. The time I have spent in the principal deputy position has given me valuable perspective on the unique role the Military Health System (MHS) plays in national security and in American medicine. I’m deeply grateful for the opportunity to serve in the ASD role and alongside such a talented team that makes up the MHS.
As I told the Senate Armed Services Committee last November, it will be a great privilege to lead the MHS during this period of unprecedented transformative change. With readiness of our service members as our first priority, we are implementing a historic transition in how we manage our Military Treatment Facilities. We are also conducting comprehensive reviews of the Direct Care System to enhance MTF operations as training platforms to support medical readiness, and identifying the optimal military medical manpower requirements to meet operational requirements. As you know, we continue the deployment of a truly modern electronic health record that will support the provision of integrated, standardized care across the MHS enterprise. Next month, MHS GENESIS will go live at Travis AFB, Mountain Home AFB, NAS Lemoore, and the Presidio at Monterey. This next deployment has been informed by the hard work of the teams at Fairchild Air Force Base, Naval Health Clinic Oak Harbor, Naval Hospital Bremerton and Madigan Army Medical Center during the Initial Operating Capability (IOC) rollout. Earlier this month I had the opportunity to visit COL Thomas Bundt, Commander, Madigan Army Medical Center (MAMC), and his team. Their passionate embrace of the opportunity to be one of the IOC sites has paid off for the entire enterprise. Their contributions to our strategy for future deployment – informed by their lessons learned on the ground – has positioned us for a successful next phase of MHS GENESIS implementation. Thank you, COL Bundt and the entire MAMC team.
In addition to the major reform efforts underway, our day-to-day successes continue to support the Department’s priorities. Earlier this week, I joined the more than 3,000 researchers and scientists from across the Department, interagency, industry, academia, and partner nations at the annual Military Health System Research Symposium (MHSRS).
I spoke to participants about the critical role of military medical research and development in advancing the MHS’s integrated system of readiness and health. From strengthening Traumatic Brain Injury clinical and research capabilities, addressing mental and behavioral health issues among injured service members, vaccines and countermeasures for infectious diseases, to the developments in medical technologies to advance enroute patient care, the MHS’s research and development initiatives enable the U.S. military to remain at the forefront to protect and defend the U.S. homeland and the shared interests of our allies and partners. I encourage you to review the innovative findings coming out of this year’s conference at www.health.mil/mhsrs.
I had the pleasure to recognize a number of MHSRS award winners – awardees like CDR Ian Valerio, who has made pivotal contributions to research on preemptive treatments for phantom and residual limb pain; and the Zika Purified Inactivated Virus WRAIR team, who helped develop a Zika vaccine candidate for clinical trial; and Dr. Amy Adler, whose research in military behavioral health has led to improved outcomes in health, resilience, and performance of service members. It is abundantly clear how the MHS’s commitment to innovation and partnerships is yielding new technologies, processes, and services that help ensure a more prepared, stronger and more resilient force.
A big thank you to Dr. Terry Rauch and the Health Affairs team, RADM Mary Riggs and the R&D team at DHA, Dr. Richard Thomas and his team at USUHS, the Services, and the thousands of scientists and researchers across the MHS who contributed to MHSRS. Thank you for your continued work in advancing the incredibly important mission we are privileged to carry out.